Ansulin 50/50 100IU Vial
415.00৳ Vial
- Larsulin is tailored for type 1 and type 2 Diabetes Mellitus management.
- Formulated with Insulin Human derived through DNA recombinant technology, Larsulin mimics natural insulin’s function.
- Various formulations cater to individual needs, ensuring personalized treatment.
- Administer Larsulin subcutaneously before meals for reliable glycemic control.
- Trust Larsulin for comprehensive diabetes care solutions.
Brand |
Square Pharmaceuticals PLC |
---|---|
Generics |
Insulin Human [rDNA] |
Indications
Larsulin is prescribed for both type 1 and type 2 Diabetes Mellitus.
Composition
Larsulin comes in various formulations:
- Insulin Human R Injection 40 IU/ml and 100 IU/ml
- Insulin Human N Injection 40 IU/ml and 100 IU/ml
- Insulin Human 30/70 Injection 40 IU/ml and 100 IU/ml
- Insulin Human 50/50 Injection 100 IU/ml
Pharmacology
Larsulin, derived through DNA recombinant technology, mimics natural insulin’s structure and function. It regulates glucose metabolism, facilitating glucose uptake by liver, muscles, and fat tissue. Its effects vary based on the formulation.
Dosage
Dosage and administration times vary among patients and are influenced by factors like food intake and physical activity. Type 1 diabetic patients typically require 0.5 to 1.0 IU/kg/day, while initial dosages for type 2 diabetic patients are often lower.
Administration
Inject Larsulin subcutaneously 15 minutes to one hour before meals. Proper preparation involves cleaning hands, mixing the solution, and selecting an injection site. Rotate injection sites to avoid tissue damage.
Interaction
Be cautious when using Larsulin with drugs affecting blood glucose levels. Dosage adjustments may be necessary based on concurrent medications.
Contraindications
Avoid Larsulin in patients with hypoglycemia or hypersensitivity to insulin or any of its components.
Side Effects
Common adverse effects include hypoglycemia and potential allergic reactions. Hypoglycemia symptoms may occur suddenly.
Pregnancy & Lactation
Insulin treatment during pregnancy poses no risk to the fetus. It’s safe for nursing mothers as insulin does not pass through breast milk.
Precautions & Warnings
Inadequate dosing may lead to hyperglycemia, while excessive dosing can cause hypoglycemia. Hypoglycemia risk increases with missed meals or strenuous exercise.
Overdose Effects
Excessive insulin use may result in hypoglycemia. Immediate treatment is necessary. Consult a doctor for changes in therapy or lifestyle to prevent hypoglycemia recurrence.
Therapeutic Class
Larsulin belongs to the class of Medium Acting Insulin.
Storage Conditions
Store Larsulin in the refrigerator at 2°C-8°C, avoiding freezing. Insulin for immediate use can be kept at room temperature for up to a month, away from heat and light.
Reviews
There are no reviews yet.